Akash Patel

Palvella Therapeutics Achieves Landmark Year, Sets Stage for FDA Approval and Commercialization of Rare Disease Therapies

PVLA

Palvella Therapeutics Achieves Landmark Year, Sets Stage for FDA Approval and Commercialization of Rare Disease Therapies

Palvella Therapeutics has marked a significant milestone in its journey towards becoming the leading rare disease biopharmaceutical company. In a recent conference call to discuss its full year 2025 financial results, the company highlighted several value-creating milestones achieved during the year. One of the most notable achievements was the announcement

By Akash Patel